STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. The company operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. It offers a range of products including cleaning chemistries, sterility assurance products, automated endoscope reprocessing systems, surgical tables, lights, and connectivity solutions. It also provides services such as equipment maintenance, instrument repair, and contract sterilization for medical device and pharmaceutical manufacturers.
CEO: Daniel A. Carestio. Company website
STERIS plc (STE) trades at $205.04, down 1.44% on the day, as of Sep 20, 2026 14:59 UTC.
STERIS plc has a market capitalisation of $19.98B, calculated from the live STE share price and shares outstanding.
STE trades at a trailing P/E of 25.07, from earnings per share of $8.18 over the last twelve months.
STERIS plc generated revenue of $6.04B over the trailing twelve months, which puts the stock at 3.31 times sales.
Yes. STERIS plc pays a dividend yielding 0.90% on the current share price.
STE has traded between $195.14 and $269.44 over the past 52 weeks, and the last price is 23.9% below that high.
Yes. STERIS plc keeps 13.33% of revenue as net income over the trailing twelve months.
Wall Street analysts rate STE Buy, with an average price target of $271.33, 32.3% above the current price.
STERIS plc is classified under the Healthcare sector and the Medical - Specialties industry, and is domiciled in US.
Daniel A. Carestio is the chief executive of STERIS plc, which employs 17,937 people.
QFI Terminal shows STE with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open STE in Terminal See plans